Dr. Lopez-Ruiz has completed his PhD from Valencia University and postdoctoral studies from CEU Cardenal Herrera Health Sciences Faculty. She obtained her doctorate in Medicine with the doctoral thesis on “Analysis of the use of medication in the paediatric population that visit accident and emergency department” with summa cum laude. She has achieved the qualification of “University Expert in Neonatology” from the Catholic University in Valencia. She is Medicine Degree Coordinator in CEU Cardenal Herrera University since 2015. She has attended to International Congresses of Pediatrics as a keynote speaker and she has published more than 20 papers in reputed journals.

Pediatrics ; Neonatology

B.B. education: BA (Hons), MA, Nat. Sci., Cambridge; D.Phil. Biochemistry, Sussex (R.C. Bray); Postdoc UEA (A.J. Thomson OBE) and Utah State (R.C. Holz). Research positions: CCLRC Daresbury Laboratory; EU Fellowship, Fachrichtung Biophysik, Universität des Saarlandes. Faculty positions: 2001-2014, Medical College of Wisconsin; 2014-present, Chair and Wehr Distinguished Professor of Physics, Marquette University, Milwaukee, WI, USA.He has published more than 100 papers in reputed journals.

Physics ; Bio-chemistry

Prof. John Lazarchick is Chairman of Clinical Pathology. He is Professor of Oncology. He is at present an active member of association of clinical scientist and American Society of Clinical Pathology. His research topic is Clinical Pathology.

Clinical Pathology

Dr. Rajyalakshmi Luthra has completed her fellowship from Osmania University. She has achieved the Board Certification from New York State Department of Health Certificate of Qualificastion.She has published more than 234 articles in reputed journals.

Hematopathology

I graduated from the NYC High School of Music and Art in 1953 as a Trombone major. I then graduated from Columbia in Chemical Engineering in 1958 and got my PhD in Chemical Engineering from University of Michigan in 1964. I taught Chemical Engineering at San Jose State University in California until 1974 when I joined the U.S. EPA to work on air pollution science. In 1981 I was a Visiting Scholar of Air Pollution at the Harvard School of Public Health where I learned about SIDS, and I have been working on it ever since. I then served with WHO from 1987-1993 as an air pollution expert in KL Malaysia and Geneva when I retired and returned to USEPA. I retired from EPA in 1999 and worked at Temple University on Survey Research until 2006. I now live in Newark, Delaware, with my wife and collaborator on SIDS, Dr. Maria Donner (PhD Genetics, Helsinki) where we still study the age and gender distributions of SIDS. He has published more than 100 papers in reputed journals.

My current interest is modeling the age distribution and gender distribution of Sudden Infant Death Syndrome, and validating an X-linkage model for explaining the 50% male excess of SIDS. I have some 130 publications on air quality modeling and SIDS, amongst others, which can be found by going to Google Scholar and searching David Mage

Hiroyuki Shimada has completed his MD and PhD at Yokohama City University School of Medicine and Ohio State University College of Medicine. He is Professor of Pathology at University of Southern California Keck School of Medicine, the founder of International Neuroblastoma Pathology Classification, and director of the COG Neuroblastoma Pathology Reference Laboratory. He has been reviewing ~700 neuroblastoma cases/year from US, Canada, Australia, and New Zealand, and participating in various clinical and translational research activities in the filed of pediatric oncology. He authored/co-authored >180 peer-review papers and made >40 invited lectures and keynote addresses at the national/international scientific meetings.

Pediatrics Research